{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.034, "exchange": "FRA", "shortName": "DIAGONAL BIO AB", "longName": "Diagonal Bio AB (publ)", "messageBoardId": "finmb_713710944", "exchangeTimezoneName": "Europe/Berlin", "market": "dr_market", "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.034, "regularMarketDayRange": "0.034 - 0.034", "regularMarketDayLow": 0.034, "regularMarketVolume": 100, "regularMarketPreviousClose": 0.034, "bid": 0.036, "ask": 0.041, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.034, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.034 - 0.655", "fiftyTwoWeekHighChange": -0.621, "fiftyTwoWeekHighChangePercent": -0.9480916, "fiftyTwoWeekLow": 0.034, "fiftyTwoWeekHigh": 0.655, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.15, "sharesOutstanding": 34765600, "fiftyDayAverage": 0.03834, "fiftyDayAverageChange": -0.0043399967, "fiftyDayAverageChangePercent": -0.113197625, "twoHundredDayAverage": 0.13452598, "twoHundredDayAverageChange": -0.10052598, "twoHundredDayAverageChangePercent": -0.7472607, "marketCap": 1259564, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Diagonal Pharma Ab", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1626415200000, "priceHint": 4, "regularMarketChange": 0.0, "symbol": "9F1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "The Spark", "address2": "Medicon Village Scheelev\u00c3\u00a4gen 1", "city": "Lund", "zip": "223 81", "country": "Sweden", "phone": "46 7 35 26 27 59", "website": "https://diagonalbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. It is involved in developing the Panviral platform for detecting and diagnosing small sections of pathogen genomes, such as viruses, bacteria, and fungi. The company was incorporated in 2020 and is headquartered in Lund, Sweden.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jack Egelund Madsen", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andreas  Nyberg", "title": "Founder & Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kushagr  Punyani", "age": 31, "title": "Tech Advisor, Founding Partner & Director", "yearBorn": 1991, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Johan  Kallstrand", "title": "Founding Partner", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Per  Heander", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}